Search Results - "Inui, Genki"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sjögren's Syndrome by Tomita, Katsuyuki, Tokugawa, Shinnosuke, Inui, Genki, Moriyasu, Shotaro, Ikeuchi, Tomoyuki, Touge, Hirokazu, Tajima, Fuminari

    Published in Internal Medicine (01-11-2022)
    “…Primary Sjögren's syndrome (pSS) has multi-dimensional manifestations, including neutropenia and polyneuropathy. We herein report a 76-year-old woman with pSS…”
    Get full text
    Journal Article
  2. 2

    Clinical characteristics for distinguishing between acute cardiogenic pulmonary edema and community-acquired pneumonia in elderly patients: a prospective observational study by Inui, Genki, Tomita, Katsuyuki, Fukuki, Masaharu, Touge, Hirokazu, Ikeuchi, Tomoyuki, Hisatome, Ichiro, Yamasaki, Akira

    Published in Monaldi archives for chest disease (01-08-2023)
    “…Heart failure and pneumonia are highly prevalent in elderly patients. We conducted a study to evaluate the differences in the patterns of symptoms, laboratory…”
    Get full text
    Journal Article
  3. 3

    Differences in the effectiveness of single, dual, and triple inhaled corticosteroid therapy for reducing future risk of severe asthma exacerbation: A systematic review and network meta-analysis by Yamasaki, Akira, Tomita, Katsuyuki, Inui, Genki, Okazaki, Ryota, Harada, Tomoya

    Published in Heliyon (30-06-2024)
    “…The effectiveness of different combinations of inhaled corticosteroid (ICS) therapies in reducing severe exacerbations of adult asthma remains unclear. This…”
    Get full text
    Journal Article
  4. 4

    The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi by Harada, Tomoya, Inui, Genki, Ishikawa, Hiroki, Kato, Ryohei, Sueda, Yuriko, Funaki, Yoshihiro, Takata, Miki, Okazaki, Ryota, Morita, Masato, Kitatani, Shin, Yamasaki, Akira

    Published in YONAGO ACTA MEDICA (2023)
    “…[ABSTRACT] [Background] Allergic bronchopulmonary mycosis (ABPM) occurs with fungi, other than Aspergillus fumigatus. However, the clinical characteristics of…”
    Get full text
    Journal Article
  5. 5

    Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications by Listyoko, Aditya Sri, Okazaki, Ryota, Harada, Tomoya, Inui, Genki, Yamasaki, Akira

    Published in Frontiers in allergy (18-03-2024)
    “…The prevalence of obesity among asthma patients has surged in recent years, posing a significant risk factor for uncontrolled asthma. Beyond its impact on…”
    Get full text
    Journal Article
  6. 6

    Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes by Listyoko, Aditya Sri, Okazaki, Ryota, Harada, Tomoya, Inui, Genki, Yamasaki, Akira

    Published in Frontiers in medicine (2024)
    “…Asthma remains a significant global health challenge. While both the incidence and mortality rates have shown a decline, older individuals with asthma exhibit…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Predictive Model for Adverse Events and Immune Response Based on the Production of Antibodies After the Second-Dose of the BNT162b2 mRNA Vaccine by Okada, Shinichi, Tomita, Katsuyuki, Inui, Genki, Ikeuchi, Tomoyuki, Touge, Hirokazu, Hasegawa, Junichi, Yamasaki, Akira

    Published in Yonago acta medica (2022)
    “…The BNT162b mRNA vaccine for coronavirus disease 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mimics the immune…”
    Get full text
    Journal Article
  9. 9

    Pembrolizumab-induced asthma exacerbation with hypereosinophilia and elevated interleukin-5 in endometrial cancer: A case report by Harada, Tomoya, Uetani, Naoki, Inui, Genki, Ishikawa, Hiroki, Funaki, Yoshihiro, Takata, Miki, Okazaki, Ryota, Yamaguchi, Kosuke, Morita, Masato, Kitatani, Shin, Yamasaki, Akira

    Published in Respiratory medicine case reports (01-01-2024)
    “…Pembrolizumab is an anti-programmed cell death-1 (PD-1) antibody used to treat various cancer types. Treatments with such immune checkpoint inhibitors cause…”
    Get full text
    Journal Article
  10. 10

    Allergic bronchopulmonary mycosis caused by Scedosporium apiospermum: A case report by Okazaki, Ryota, Arita, Shino, Hoshio, Hinako, Uetani, Naoki, Inui, Genki, Ishikawa, Hiroki, Nonaka, Takafumi, Kohno, Hiroki, Funaki, Yoshihiro, Harada, Tomoya, Morita, Masato, Watanabe, Akira, Yamasaki, Akira

    Published in Respiratory medicine case reports (01-01-2024)
    “…A 61-year-old woman, hospitalized for a persistent cough and dyspnea, had no history of bronchial asthma, but was undergoing chemotherapy for…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Cobblestone Throat in a Younger Patient Infected with the Omicron Variant of the SARS-CoV-2 Virus by Inui, Genki, Tomita, Katsuyuki, Yamasaki, Akira

    “…A 21-year-old woman without a history of tobacco use presented to the emergency department (ED) with a 1-day history of an acute scratchy throat and fever. She…”
    Get full text
    Journal Article
  13. 13

    Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sjögren's Syndrome by Tomita, Katsuyuki, Tokugawa, Shinnosuke, Inui, Genki, Moriyasu, Shotaro, Ikeuchi, Tomoyuki, Touge, Masakazu, Tajima, Fuminari

    Published in Internal Medicine (2022)
    “…Primary Sjögren's syndrome (pSS) has multi-dimensional manifestations, including neutropenia and polyneuropathy. We herein report a 76-year-old woman with pSS…”
    Get full text
    Journal Article
  14. 14

    Predictive Model for Adverse Events and Immune Response Based on the Production of Antibodies After the Second-Dose of the BNT162b2 mRNA Vaccine by Shinichi Okada, Katsuyuki Tomita, Genki Inui, Tomoyuki Ikeuchi, Hirokazu Touge, Junichi Hasegawa, Akira Yamasaki

    Published in YONAGO ACTA MEDICA (2022)
    “…[ABSTRACT] [Background] The BNT162b mRNA vaccine for coronavirus disease 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Pembrolizumab-induced asthma exacerbation with hypereosinophilia and elevated interleukin-5 in endometrial cancer: A case report by Harada, Tomoya, Uetani, Naoki, Inui, Genki, Ishikawa, Hiroki, Funaki, Yoshihiro, Takata, Miki, Okazaki, Ryota, Yamaguchi, Kosuke, Morita, Masato, Kitatani, Shin, Yamasaki, Akira

    Published in Respiratory medicine case reports (01-01-2024)
    “…Pembrolizumab is an anti-programmed cell death-1 (PD-1) antibody used to treat various cancer types. Treatments with such immune checkpoint inhibitors cause…”
    Get full text
    Report